(Adds details, updates prices)
Oct 16 (Reuters) - Canada’s main stock index was muted on Friday as concerns over rising global infections and signs of a stalling economic recovery offset optimism over progress in a possible COVID-19 vaccine.
* At 9:39 a.m. ET (1339 GMT), the Toronto Stock Exchange’s S&P/TSX composite index was down 0.01 points at 16,501.02 and was set to edge lower for the week.
* Canadian stock futures had risen after American drugmaker Pfizer Inc said it could apply for U.S. emergency use of its COVID-19 vaccine candidate as soon as a safety milestone is achieved in the third week of November.
* But local data showed Canadian manufacturing sales fell by 2.0% in August, following three months of consecutive gains, indicating that local consumption was still under pressure from the pandemic.
* Heavyweight energy stocks dropped 1.7% tracking weaker crude prices as resurgent coronavirus cases around the globe brewed fears of declining demand.
* The financials sector gained 0.3%, while the industrials sector rose 0.2%.
* The materials sector, which includes precious and base metals miners and fertilizer companies, lost 0.5%.
* On the TSX, 87 issues rose, while 129 issues fell in a 1.48-to-1 ratio favoring losers, with 9.77 million shares traded.
* The largest percentage gainers on the TSX were Ci Financial, which rose 2.9%, and Silvercorp Metal , which rose 2.4%.
* Imperial Oil fell 2.5%, the most on the TSX, while the second biggest decliner was BRP Inc, down 2.4%.
* The most heavily traded shares by volume were Vivo Cannabs Inc, First Mining Gld, and Orosur Minng Inc .
* The TSX posted nine new 52-week highs and one new low.
* Across all Canadian issues, there were 25 new 52-week highs and three new lows, with 21.84 million shares traded.
Reporting by Ambar Warrick in Bengaluru; Editing by Vinay Dwivedi
Our Standards: The Thomson Reuters Trust Principles.